Kidney transplantation during the first trimester of pregnancy: Immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone

Transplantation

Volumn 71, Issue 7, 2001, Pages 994-997

  Pergola, Pablo E ^a,c   Kancharla, Asha ^b   Riley, Daniel J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; DRUG SAFETY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NAIL DISEASE; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; TERATOGENICITY; TREATMENT OUTCOME;

EID: 0035870675     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200104150-00028     Document Type: Article

References (10)

1. A case report of pregnancy in a renal transplant recipient treated with FK506 (tacrolimus)
2. Pregnancy after cardiac transplantation
3. Pregnancy after liver transplantation under tacrolimus
4. Induction of meiotic maturation in vivo in the mouse by IMP dehydrogenase inhibitors: Effects on the developmental capacity of ova
5. From mice to man: The preclinical history of mycophenolate mofetil
6. Identical phalangeal defects induced by phenytoin and nifedipine suggest fetal hypoxia and vascular disruption behind phenytoin teratogenicity
7. Renal transplantation in early pregnancy
8. Renal allotransplantation during pregnancy: Successful outcome for mother, child, and kidney
9. Renal transplantation during pregnancy
10. Medical management of the pregnant transplant recipient